Macquarie University Hospital — Sydney, New South Wales

Public research footprint of Macquarie University Hospital, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Advanced Solid Tumors · Solid Tumors · Metastatic Castration-Resistant Prostate Cancer · NSCLC (Advanced Non-small Cell Lung Cancer)

Recently updated registry entries

NCT07711184 — A Clinical Study of HRS-7525 Tablets in Patients With Advanced Prostate Cancer (Recruiting)
NCT04640623 — A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in… (Active Not Recruiting)
NCT06710132 — Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Macquarie University Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.